The pediatric tube feeding sales are anticipated to grow at a CAGR of 7.0% from 2024 to 2034 and is estimated to reach USD 2,342.6 million in 2034 from a value of USD 1,670.1 million in the year 2024.
Pediatric tube feeding sales have seen a surge in the past few years because of various reasons such as an increase in the number of babies born preterm, babies born with dysphagia and other congenital and neurological disabilities.
A report by the WHO says that approximately 13.4 million babies were born preterm, in exact values, approximately 1 in 10 kids, globally are born prematurely. Nearly 1 million, was the number of infants who died due to the complications of prematurity in 2019.
Parents are also seeking products that cater to their specific needs like certain dietary preferences, allergen-free formulas, and less invasive tube placement. Manufacturers are working their way to satisfy the demand in the market by making new formulas and products that align with the needs of the parents.
| Attributes | Description |
|---|---|
| Estimated Pediatric Tube Feeding Size (2024E) | USD 1,670.14 million |
| Projected Pediatric Tube Feeding Value (2034F) | USD 2,342.69 million |
| Value-based CAGR (2024 to 2034) | 7.0% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
More Emphasis given to Caregiver Training and Support for Pediatric Tube Feeding
The manufacturers of pediatric tube-feeding products are placing great emphasis on educating and supporting parents who are primary caregivers of children to ensure proper tube-feeding management and patient safety at home.
Leading players such as Abbott Nutrition and Health Institute have come up with a parent’s guide for tube feeding at home which includes all the information a parent needs to have regarding tube feeding their child properly and safely. Nestle is providing a Pediatric Nutrition in Practice program that aims to inform healthcare professionals on issues surrounding nutrition related to children.
Even the governments of many countries such as the USA, European Union, Australia, and Canada have mandated that caregivers undergo training for home-based tube feeding for improved knowledge of caregivers and to ensure the safety of patients.
New formula delivery methods drastically increase the use of Home Enteral Nutrition(HEN) Therapy
The method that is getting a boost nowadays is called the Bolus method where food is administered at regular intervals via syringe or pump, what caused a rise in the Bolus feeding method is its ease of administration.
It is similar to natural eating habits, and a new cap-based feeding system allows convenient and secure administration of formula without the need for a syringe or pump, a collapsible bottle with a specialized cap that directly attaches to the feeding tube allows direct delivery from formula bottle to feeding tube reducing the time of feed administration significantly and reducing the chances of contamination by not reusing the equipment.
This specialized cap was developed by Nestle in 2021.
Rise in demand for organic and vegan Pediatric Feeding Formula
For the last few years, there has been a growing demand for more specialized and alternative pediatric tube-feeding formulas to cater to dietary preferences and medical needs. One notable trend is the introduction of vegan and organic tube-feeding options for children.
Parents following vegan and organic diets ask for similar diet options for their children and some leading nutrition companies have responded to these demands of parents by creating completely plant-based and organic tube-feeding formulas for pediatric patients.
These formulas utilize alternative sources of nutrition that align with vegan and organic approaches, some products created by these companies even have no GMO ingredients and also without any common allergens, making products that can be consumed by anyone.
For instance, Nestle Medical Hub offers a pediatric-specific tube feeding formula called Compleat Pediatric Standard 1.0 which is plant-based, organic, with no GMO ingredients included, and no common allergens with all the same nutritional values as normal formulas.
The historic sales of the pediatric tube feeding from 2019 to 2023 were growing with a CAGR of 5.3% and, over the next ten years, the pediatric tube feeding industry is forecasted to rise steeply at a 7.0% CAGR from 2024 to 2034.
The period from 2019 to 2023 marks the gradual growth in pediatric tube feeding boosted by the increasing cases of pediatric feeding disorder and fast growth in adopting home-based tube feeding. These pediatric tube feeding products have been continuously selling over this period and contributing to an increase in and propelling demand for these vital medical devices and nutritional solutions.
The market has grown through increases in the prevalence of diseases and disorders, particularly dysphagia, prematurity, and neurological disorders, which result in tube feeding. The second factor is the technological advancements in tube feeding, which make it more comfortable and user-friendly, with the development of devices that have further expanded this market.
Looking ahead to 2024-2034, growth in pediatric tube feeding is anticipated to be on the rise, with interest-generated forecasts indicating durable and continued expansion.
Of the demand driving factors, increasingly received notions about children's nutritional requirements while in care, the development of home-based tube feeding, and advancing levels of minimally invasive tube placement are expected to be very significant. Increasing emphasis on personalized nutrition and preparation of specifically crafted tube feed formulas that would suit each patient will keep on growing the sales.
Principal Consultant
The pediatric tube feeding is considered to be organized and concentrated, with the majority of the share owned by the top players. Tier 1 companies include Abbott, Nestle, Kate Farms, Mead Johnson, and Nutricia. These companies are the industry giants dominating the market.
These companies are considered Tier 1 companies because of their diverse product portfolio, global presence, advanced and leading technologies, and strong brand recognition. They have the resources, infrastructure, and global reach that keep them at the top of the market, thereby enabling heavy investment in research and development, marketing, and distribution to service a wide customer base.
Companies that make up the Tier 2 concentration include Ajinomoto Cambrooke, Real Food Blends, and Functional Formularies. These are still Tier 2 companies, as they usually have smaller market shares and become far more focused on narrower product segments and/or geographic regions.
Even though tier 2 companies may have narrower product ranges and less complex distribution networks compared with tier 1 players, at the same time, very often they also focus on niche markets or bring out innovative products that suit certain customer needs.
These companies do have the potential to scale and, based on the relevant criteria, could migrate into Tier 1 over some time, provided they continue to widen their market presence and competitiveness.
| Countries | CAGR 2024 to 2034 |
|---|---|
| United States | 4.6% |
| Germany | 5.7% |
| China | 8.6% |
| India | 7.8% |
| Japan | 6.0% |
The Pediatric Tube Feeding sales is evaluated to reach a CAGR of 4.6% by 2024 in the United States. By 2034 the market is anticipated to cross USD 442.7 million.
According to the CDC, across the United States in 2020, one in ten birth events was preterm, accounting for 10.5% of births. Premature births in the United States are high. The CDC looks at this as a serious public health problem because most of the premature babies are born with birth defects and conditions.
However, the USA has been conquering such challenges with its favorable policies and sophisticated, advanced medical technologies like tube-feeding products. However, such growth for specialized products and technologies in the USA has contributed to becoming one of the high percentage factors of babies born with birth defects and chronic conditions.
This mix of preterm births, birth defects, and chronic conditions raises the realization that further research in health policy and responsible development and use of advanced medical technologies are to be continued if the well-being of newborns and infants in the United States is to be secured.
Pediatric tube feeding use is expected to grow at a CAGR of 8.6% in China from 2024-2034. The changing awareness across the country about nutrition intake in children can be correlated with the growing demand for pediatric feeding products in China. With plans by the Chinese government to upgrade healthcare and create specialized pediatric care, the pediatric tube feeding has maximally expanded.
This is against the backdrop of a worrying trend in malnutrition among children in China; in this respect, the National Health Commission had 6.1% of its children under five diagnosed with malnutrition in 2020.
Likewise, the growth of the pediatric feeding disorders market and government initiatives toward strengthening child health care are events that augur well for the prospect of the tube feeding market within this country. This trend will see companies manufacturing specialized pediatric feeding products emerge as the biggest gainers while trying to plug nutritional deficiencies into China's vulnerable youth population.
According to the research study, the German pediatric tube-feeding sales will grow at a CAGR of 5.7%. That is attributed to several factors: the advanced UK healthcare system, an increasing population that needs specialized pediatric care, and the National Institute for Health and Care Excellence publishing guidelines in the reviewed time on enteral tube feeding in children and young people.
The guidelines set the basis with evidence-based recommendations for healthcare professionals to ensure quality, uniformity, and cost-effectiveness of care in Pediatric patients who require tube feeding. Factors that act as catalysts for the growth of the German industry include the increasing adoption of sophisticated feeding technologies and a rise in chronic conditions among children.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Segment | Standard (Formula Type) |
|---|---|
| Value Share (2024) | 34% |
Sales of Standard Pediatric Tube Feeding Formula are expected to reach a CAGR of 7.8% from 2024 to 2034. Standard formulas are the most commonly used and accepted type of formula for pediatric tube feeding due to a variety of reasons.
This group of formulas, with standard quality, meets the requirements for the nutritional support of children whose digestive tract functions are not disturbed and can be employed in pediatric tube feeding for children of any age-from infancy to adolescence.
In addition, standard formulas are much more regulatory and better controlled for safety and quality than other groupings of formulas, tend to be more readily and easily available and distributed, and are also less costly than speciality enteral formulas.
Nutritional completeness, extensive utility, high regulation, low consumables, and cost-effectiveness have placed the standard formulas as the most dominantly preferred choice in the pediatric tube feed market.
| Segment | Infant (Age) |
|---|---|
| Value Share (2024) | 38% |
The infant segment, consisting of infants under 12 months of age, is the most dominant and fastest-growing segment of the pediatric tube feeding market. This segment is projected to grow at a CAGR of 6.7% from 2024 to 2034.
One large chunk, about 38%, of the pediatric tube feeding market is consumed by infants, followed by toddlers and older children. This is because, in the infant population, incidents of medical conditions and developmental difficulties are more frequent, hence requiring enteral nutrition support.
Infants are born with more birth defects, neurological conditions, or issues with oral feeding, so they require even more specialized tube feeding solutions that are oriented toward arresting improper physiology. Bottle-fed babies still have smaller bodies, tender gastrointestinal tracts, and greater nutritional needs per kilogram of body weight, which means they need specific tube-feeding products and formulas.
Moreover, increasing awareness with respect to the prime nutrition imperative in infant development, together with neonatal and pediatric care also helps drive the growth of tube-feeding solutions in the infant population. This is being backed up by a focus among manufacturers and health professionals on the development of innovative products in the fields of safety, efficacy, and comfort in tube feeding for this vulnerable age group.
The pediatric feeding tube market henceforth is a fiercely competitive landscape for some leading companies vying in the market for share. The Rise in disorders among preterm delivered babies compels the use of feeding tubes for nutritional support, driving market growth.
Product innovation to meet the diverse needs of pediatrics is generally the umbrella under which the leading companies commanding a market share in pediatric feeding tubes operate. Such companies mainly invest in research and development for introducing innovative designs, materials, and technologies of feeding tubes toward better patient comfort, safety, and clinical outcomes.
For Example
The pediatric tube feeding is expected to grow at a CAGR of 7.0% from 2024 to 2034.
The pediatric tube feeding market is estimated to reach a value of USD 1,670.14 million in 2024.
The Tier 1 companies dominating the pediatric tube feeding sales are industry giants such as Abbott and Nestle, which have large value share, extensive product portfolios, and strong brand recognition.
The region of North America is anticipated to contribute the biggest share in 2024 of the global sales for pediatric tube feeding.
China holds a share of 14% in the global pediatric tube feeding.
1. Executive Summary 2. Industry Introduction, Including Taxonomy and Market Definition 3. Market Trends and Success Factors, Including Macro-Economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 6.1. Formula Type 6.2. Age 6.3. Feeding Method 6.4. Form 6.5. Specific Needs 6.6. Dietary Preference 6.7. Distribution Channel 6.8. Region 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Formula Type 7.1. Standard 7.2. Peptide-Based 7.3. Elemental/Amino Acid Based 7.4. Specialty 7.5. Blenderized 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Age 8.1. Infant (less than 12 months old) 8.2. Toddler (1 to 3 years old) 8.3. Children (4 to 12 years) 8.4. Teenager (13 to 18 years old) 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Feeding Method 9.1. Bolus 9.2. Intermittent 9.3. Continuous 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Form 10.1. Liquid 10.2. Powder 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Specific Needs 11.1. Impaired - GI tolerant formula 11.2. Milk-protein free formula 11.3. Common allergen-free formula 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Dietary Preference 12.1. Vegan 12.2. Organic 13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Distribution Channel 13.1. Hospital Pharmacy 13.2. Retail Pharmacy 13.3. Online Retail 14. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 14.1. North America 14.2. Latin America 14.3. Europe 14.4. East Asia 14.5. South Asia 14.6. Oceania 14.7. Middle East and Africa 15. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 18. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 19. South Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 20. Oceania Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 21. Middle East and Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 22. Sales Forecast 2024 to 2034 by Formula Type, Age, Feeding Method Form, Specific Needs, Dietary Preference, Distribution Channel for 30 Countries 23. Global Market Structure Analysis 2019 to 2023 and Forecast 2024 to 2034 24. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 25. Company Profile 25.1. Abbott 25.2. Nestle 25.3. Kate Farms 25.4. Mead Johnson 25.5. Nutricia 25.6. Ajinomoto Cambrooke 25.7. Real Food Blends 25.8. Functional Formularies 26. Assumptions and Acronyms 27. Research Methodology
Explore Food and Beverage Insights
View Reports
Pediatric Tube Feeding Market
